Publicacións nas que colabora con Fernando Alfonso Manterola (71)

2024

  1. A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767

2023

  1. Cierre de la orejuela izquierda frente a anticoagulantes orales en FA e implante de stents coronarios. Registro DESAFIO

    REC: Interventional Cardiology, Vol. 5, Núm. 4, pp. 287-296

  2. Transcatheter aortic valve implantation in patients with extra-small aortic annuli

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 4, pp. e340-e351

2022

  1. Justificación y diseño del estudio Concordancia entre RFF e iFR en lesiones del tronco común.: Estudio iLITRO-EPIC-07

    REC: Interventional Cardiology, Vol. 4, Núm. 1, pp. 19-26

  2. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396

  3. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  4. Stents recubiertos o farmacoactivos en aneurismas, resultados del Registro Internacional de Aneurismas Coronarios (CAAR)

    REC: Interventional Cardiology, Vol. 4, Núm. 2, pp. 107-114

2021

  1. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  2. Outcomes of nonagenarians after transcatheter aortic valve implantation

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257

  3. Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting

    EuroIntervention, Vol. 16, Núm. 3, pp. 210-217

  4. Pronóstico de pacientes nonagenarios tras implante percutáneo de válvula aórtica

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257

  5. Spontaneous coronary artery dissection in Spain: clinical and angiographic characteristics, management, and in-hospital events

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 15-23

2020

  1. Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: A pooled analysis of individual patient data

    EuroIntervention, Vol. 14, Núm. 16, pp. 1451-1457

  2. Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial

    EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921

2019

  1. Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011

  2. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 154-159

  3. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70

  4. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

    Circulation, Vol. 140, Núm. 23, pp. 1904-1916

  5. Mitral Regurgitation and Prognosis After Non-ST-Segment Elevation Myocardial Infarction in Very Old Patients

    Journal of the American Geriatrics Society, Vol. 67, Núm. 8, pp. 1641-1648

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991